Home / Knowledge Center /
Article

Manufacturing Chemist Interview: Alistair Hay Head of Peptide Business and Process Development

From dark art to an age of enlightenment
Dr Kevin Robinson sits down with Almac Sciences’ Alistair Hay to discuss the recent happenings in Almac’s GMP peptides business, in terms of growth, development and strategic operations. They also discuss the company’s current focus on neoantigen-derived vaccines that harness the body’s own immune system to fight cancer.
Read the full article below

View Resource
Manufacturing Chemist Interview: Alistair Hay Head of Peptide Business and Process Development

Please complete this form to view the Article

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies